Mobile Site ›

Monitoring Monoclonal Gammopathies

Monoclonal Gammopathies: Primary Systemic Amyloidosis

Slide 1

November 2009

With the use of the serum M-spike and Ig quantitation and urine M-spike, there still are some patients with no measurable disease. This slide shows the serum and urine electrophoresis results for a patient with primary amyloid. There is a faint monoclonal lambda band visible in the urine immunofixation gel, but there is no M-spike to monitor this disease even though this patient has proteinuria and a life-threatening disorder.

Primary Amyloidosis


Jump to section: